Phosphodiesterase 3A rs7134375 single nucleotide polymorphism and serum lipid levels

Wang,Wei; Yin,Rui‑Xing; Wu,Dong‑Feng; Aung,Lynn Htet Htet; Huang,Ping; Zeng,Xiao‑Na; Huang,Ke‑Ke; Lin,Quan‑Zhen; Wu,Jian; Guo,Tao

doi:10.3892/mmr.2014.2007

Phosphodiesterase 3A rs7134375 single nucleotide polymorphism and serum lipid levels

Authors:
- Wei Wang
- Rui‑Xing Yin
- Dong‑Feng Wu
- Lynn Htet Htet Aung
- Ping Huang
- Xiao‑Na Zeng
- Ke‑Ke Huang
- Quan‑Zhen Lin
- Jian Wu
- Tao Guo
View Affiliations

Affiliations: Department of Cardiology, Institute of Cardiovascular Diseases, The First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
Published online on: March 4, 2014 https://doi.org/10.3892/mmr.2014.2007
Pages: 1618-1628
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The association between the phosphodiesterase 3A (PDE3A) rs7134375 single nucleotide polymorphism (SNP) and serum lipid levels are not well understood in the general population. The present study was performed in order to detect the association between the rs7134375 SNP and serum lipid levels in the Guangxi Mulao and Han populations. The genotypes of the PDE3A rs7134375 SNP in 761 subjects of the Mulao population and 774 subjects of the Han Chinese population were determined by polymerase chain reaction and restriction fragment length polymorphism combined with gel electrophoresis, and then confirmed by direct sequencing. It was observed that serum low‑density lipoprotein cholesterol and apolipoprotein B levels were higher in the Mulao population than in the Han population (P<0.05 for each). The frequencies of the C and A alleles were 72.14 and 27.86% in the Mulao population, and 78.55 and 21.45% in the Han population (P<0.01), respectively. The frequencies of the CC, CA and AA genotypes were 52.04, 40.21 and 7.75% in the Mulao population, and 61.50, 34.11 and 4.39% in the Han population (P<0.01), respectively. The frequencies of the C and A alleles were 74.89 and 25.11% in Mulao females, and 68.08 and 31.92% in Mulao males (P<0.01), respectively. The serum triglyceride (TG) levels were different among the genotypes in the Mulao population; however, not in the Han population (P<0.01), and the A allele carriers exhibited lower TG levels than the A allele noncarriers. The serum lipid parameters were also correlated with several environmental factors in the two ethnic groups (P<0.05‑0.001). It was concluded that the genotypic and allelic frequencies of the rs7134375 SNP are different between the Mulao and Han populations. In addition, the PDE3A rs7134375 SNP is associated with serum TG levels in the Mulao population, however, not in the Han population.

View Figures

View References

1	Lopez AD, Mathers CD, Ezzati M, Jamison DT and Murray CJ: Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 367:1747–1757. 2006. View Article : Google Scholar
2	Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S and Murray CJ; Comparative Risk Assessment Collaborating Group. Selected major risk factors and global and regional burden of disease. Lancet. 360:1347–1360. 2002. View Article : Google Scholar : PubMed/NCBI
3	Law MR, Wald NJ and Rudnicka AR: Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ. 326:14232003. View Article : Google Scholar
4	Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al: Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 355:675–687. 2000. View Article : Google Scholar : PubMed/NCBI
5	Clarke R, Emberson JR, Parish S, et al: Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men. Arch Intern Med. 167:1373–1378. 2007. View Article : Google Scholar : PubMed/NCBI
6	Qian DF, Fan GL, Chen P, et al: Risk factors for hyperuricemia in active and retired employees underwent physical examination. Zhonghua Xin Xue Guan Bing Za Zhi. 41:60–64. 2013.(In Chinese).
7	Ruixing Y, Yuming C, Shangling P, et al: Effects of demographic, dietary and other lifestyle factors on the prevalence of hyperlipidemia in Guangxi Hei Yi Zhuang and Han populations. Eur J Cardiovasc Prev Rehabil. 13:977–984. 2006. View Article : Google Scholar : PubMed/NCBI
8	Ruixing Y, Qiming F, Dezhai Y, et al: Comparison of demography, diet, lifestyle, and serum lipid levels between the Guangxi Bai Ku Yao and Han populations. J Lipid Res. 48:2673–2681. 2007. View Article : Google Scholar : PubMed/NCBI
9	Ruixing Y, Yiyang L, Meng L, et al: Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels. Lipids Health Dis. 9:862010.
10	Yin RX, Li YY, Liu WY, Zhang L and Wu JZ: Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels. PLoS One. 6:e179542011. View Article : Google Scholar : PubMed/NCBI
11	Pilia G, Chen WM, Scuteri A, et al: Heritability of cardiovascular and personality traits in 6,148 Sardinians. PLoS Genet. 2:e1322006. View Article : Google Scholar : PubMed/NCBI
12	Teslovich TM, Musunuru K, Smith AV, et al: Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 466:707–713. 2010. View Article : Google Scholar : PubMed/NCBI
13	Kathiresan S, Melander O, Guiducci C, et al: Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet. 40:189–197. 2008. View Article : Google Scholar : PubMed/NCBI
14	Sandhu MS, Waterworth DM, Debenham SL, et al: LDL-cholesterol concentrations: a genome-wide association study. Lancet. 371:483–491. 2008. View Article : Google Scholar : PubMed/NCBI
15	Willer CJ, Sanna S, Jackson AU, et al: Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet. 40:161–169. 2008. View Article : Google Scholar : PubMed/NCBI
16	Wallace C, Newhouse SJ, Braund P, et al: Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet. 82:139–149. 2008. View Article : Google Scholar : PubMed/NCBI
17	López S, Buil A, Ordoñez J, et al: Genome-wide linkage analysis for identifying quantitative trait loci involved in the regulation of lipoprotein a (Lpa) levels. Eur J Hum Genet. 16:1372–1379. 2008.PubMed/NCBI
18	Aulchenko YS, Ripatti S, Lindqvist I, et al: Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet. 41:47–55. 2009. View Article : Google Scholar : PubMed/NCBI
19	Li X, Monda KL, Göring HH, et al: Genome-wide linkage scan for plasma high density lipoprotein cholesterol, apolipoprotein A-1 and triglyceride variation among American Indian populations: the Strong Heart Family Study. J Med Genet. 46:472–479. 2009. View Article : Google Scholar
20	Chasman DI, Paré G, Zee RY, et al: Genetic loci associated with plasma concentration of low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, apolipoprotein A1, and Apolipoprotein B among 6382 white women in genome-wide analysis with replication. Circ Cardiovasc Genet. 1:21–30. 2008. View Article : Google Scholar
21	Waterworth DM, Ricketts SL, Song K, et al: Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol. 30:2264–2276. 2010. View Article : Google Scholar : PubMed/NCBI
22	Zhang Z, Tao L, Chen Z, Zhou D, Kan M, Zhang D, Li C, He L and Liu Y: Association of genetic loci with blood lipids in the Chinese population. PLoS One. 6:e273052011. View Article : Google Scholar : PubMed/NCBI
23	Dumitrescu L, Carty CL, Taylor K, et al: Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet. 7:e10021382011. View Article : Google Scholar : PubMed/NCBI
24	Omori K and Kotera J: Overview of PDEs and their regulation. Circ Res. 100:309–327. 2007. View Article : Google Scholar : PubMed/NCBI
25	Bender AT and Beavo JA: Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev. 58:488–520. 2006. View Article : Google Scholar : PubMed/NCBI
26	Thompson PE, Manganiello V and Degerman E: Re-discovering PDE3 inhibitors - new opportunities for a long neglected target. Curr Top Med Chem. 7:421–436. 2007. View Article : Google Scholar : PubMed/NCBI
27	Begum N, Hockman S and Manganiello VC: Phosphodiesterase 3A (PDE3A) deletion suppresses proliferation of cultured murine vascular smooth muscle cells (VSMCs) via inhibition of mitogen-activated protein kinase (MAPK) signaling and alterations in critical cell cycle regulatory proteins. J Biol Chem. 286:26238–26249. 2011. View Article : Google Scholar
28	Sun B, Li H, Shakur Y, et al: Role of phosphodiesterase type 3A and 3B in regulating platelet and cardiac function using subtype-selective knockout mice. Cell Signal. 19:1765–1771. 2007. View Article : Google Scholar : PubMed/NCBI
29	Jeemon P, Pettigrew K, Sainsbury C, Prabhakaran D and Padmanabhan S: Implications of discoveries from genome-wide association studies in current cardiovascular practice. World J Cardiol. 3:230–247. 2011. View Article : Google Scholar : PubMed/NCBI
30	National Bureau of Statistics of the People’s Republic of China. Population distribution of 2000 census in China. http://www.stats.gov.cn/tjsj/ndsj/renkoupucha/2000pucha/html/t0201.htm.
31	Xu L, Deng QY, Li SF, Zhou LN, Gong JC and Wei BY: Genetic analysis of Mulao nationality using 15 short tandem repeats. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 25:96–100. 2008.(In Chinese).
32	Li Q, Yin RX, Yan TT, et al: Association of the GALNT2 gene polymorphisms and several environmental factors with serum lipid levels in the Mulao and Han populations. Lipids Health Dis. 10:1602011. View Article : Google Scholar : PubMed/NCBI
33	Yan TT, Yin RX, Li Q, et al: Sex-specific association of rs16996148 SNP in the NCAN/CILP2/PBX4 and serum lipid levels in the Mulao and Han populations. Lipids Health Dis. 10:2482011. View Article : Google Scholar : PubMed/NCBI
34	People’s Republic of China - United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People’s Republic of China. Baseline report from the P.R.C.-U.S.A. Collaborative Study Circulation. 85:1083–1096. 1992.
35	Wu DF, Yin RX, Hu XJ, et al: Association of rs5888 SNP in the scavenger receptor class B type 1 gene and serum lipid levels. Lipids Health Dis. 11:502012. View Article : Google Scholar : PubMed/NCBI
36	Ruixing Y, Weixiong L, Hanjun Y, et al: Diet, lifestyle, and blood pressure of the middle-aged and elderly in the Guangxi Bai Ku Yao and Han populations. Am J Hypertens. 21:382–387. 2008. View Article : Google Scholar : PubMed/NCBI
37	Zhou BF: Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases - report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 15:245–252. 2002.PubMed/NCBI
38	Hongkong SHS Group Company Limited. The Mulao ethnic minority. http://arts.imextrade.ru/education/nationalities-of-china/21-china-mulaozu/?lang=en.
39	Lincoln TM, Wu X, Sellak H, Dey N and Choi CS: Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front Biosci. 11:356–367. 2006. View Article : Google Scholar : PubMed/NCBI
40	Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:801–809. 1993. View Article : Google Scholar : PubMed/NCBI
41	Francis SH, Busch JL, Corbin JD and Sibley D: cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev. 62:525–563. 2010. View Article : Google Scholar : PubMed/NCBI
42	Aizawa T, Wei H, Miano JM, Abe J, Berk BC and Yan C: Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells. Circ Res. 93:406–413. 2003. View Article : Google Scholar : PubMed/NCBI
43	Kass DA, Takimoto E, Nagayama T and Champion HC: Phosphodiesterase regulation of nitric oxide signaling. Cardiovasc Res. 75:303–314. 2007. View Article : Google Scholar : PubMed/NCBI
44	Begum N, Shen W and Manganiello V: Role of PDE3A in regulation of cell cycle progression in mouse vascular smooth muscle cells and oocytes: implications in cardiovascular diseases and infertility. Curr Opin Pharmacol. 11:725–729. 2011. View Article : Google Scholar : PubMed/NCBI
45	Bermudez OI, Velez-Carrasco W, Schaefer EJ and Tucker KL: Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr. 76:1214–1221. 2002.PubMed/NCBI
46	Liu WY, Yin RX, Zhang L, Wu DF, Htet Aung LH, Hu XJ, Cao XL and Miao L: Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels. Alcohol. 45:681–687. 2011.